Fidelis Capital Partners LLC bought a new position in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,636 shares of the company’s stock, valued at approximately $213,000.
A number of other institutional investors also recently bought and sold shares of KMB. Catalina Capital Group LLC raised its stake in Kimberly-Clark by 8.7% during the third quarter. Catalina Capital Group LLC now owns 2,138 shares of the company’s stock worth $304,000 after purchasing an additional 171 shares during the period. Radnor Capital Management LLC purchased a new position in Kimberly-Clark during the third quarter worth about $983,000. Centennial Wealth Advisory LLC raised its stake in Kimberly-Clark by 2.6% during the third quarter. Centennial Wealth Advisory LLC now owns 4,261 shares of the company’s stock worth $606,000 after purchasing an additional 106 shares during the period. Concurrent Investment Advisors LLC raised its stake in Kimberly-Clark by 3.4% during the third quarter. Concurrent Investment Advisors LLC now owns 12,105 shares of the company’s stock worth $1,722,000 after purchasing an additional 402 shares during the period. Finally, Forte Capital LLC ADV raised its stake in Kimberly-Clark by 5.0% during the third quarter. Forte Capital LLC ADV now owns 12,075 shares of the company’s stock worth $1,718,000 after purchasing an additional 580 shares during the period. 76.29% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Kimberly-Clark news, VP Andrew Drexler sold 10,838 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $141.00, for a total transaction of $1,528,158.00. Following the completion of the transaction, the vice president now owns 7,720 shares in the company, valued at $1,088,520. The trade was a 58.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.62% of the stock is currently owned by company insiders.
Kimberly-Clark Trading Up 0.5 %
Kimberly-Clark (NYSE:KMB – Get Free Report) last posted its quarterly earnings results on Tuesday, January 28th. The company reported $1.50 EPS for the quarter, hitting the consensus estimate of $1.50. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. Equities research analysts predict that Kimberly-Clark Co. will post 7.5 EPS for the current fiscal year.
Kimberly-Clark Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 2nd. Shareholders of record on Friday, March 7th will be issued a dividend of $1.26 per share. This represents a $5.04 annualized dividend and a yield of 3.55%. The ex-dividend date is Friday, March 7th. This is a boost from Kimberly-Clark’s previous quarterly dividend of $1.22. Kimberly-Clark’s payout ratio is 66.75%.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. UBS Group boosted their price target on shares of Kimberly-Clark from $132.00 to $134.00 and gave the company a “neutral” rating in a research note on Wednesday, January 29th. Citigroup reduced their price target on shares of Kimberly-Clark from $125.00 to $118.00 and set a “sell” rating on the stock in a research note on Wednesday, January 15th. TD Cowen downgraded shares of Kimberly-Clark from a “buy” rating to a “hold” rating and set a $145.00 price target on the stock. in a research note on Wednesday, January 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $165.00 price target on shares of Kimberly-Clark in a research note on Friday, January 24th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Kimberly-Clark from $140.00 to $124.00 and set an “underweight” rating on the stock in a research note on Thursday, January 16th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $143.64.
Get Our Latest Stock Report on KMB
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Stories
- Five stocks we like better than Kimberly-Clark
- What Are Some of the Best Large-Cap Stocks to Buy?
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- P/E Ratio Calculation: How to Assess Stocks
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.